Evista is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer. Evista is not a cancer medication and will not treat breast cancer. Taking Evista may increase your risk of a blood clot in your leg, your lung, or your eye.What is Evista (raloxifene)?
Evista (raloxifene) affects the cycle of bone formation and breakdown in the body, and reduces loss of bone tissue. Evista is used to treat or prevent osteoporosis in postmenopausal women.What is the recommended dosage for eVisa?
Recommended Dosing The recommended dosage is one 60 mg EVISTA (raloxifene hydrochloride tablets) tablet daily, which may be administered any time of day without regard to meals [seeCLINICAL PHARMACOLOGY]. For the indications in risk of invasive breast cancer the optimum duration of treatment is not known [see Clinical Studies].What are the most common side effects of eVisa?
Venous Thromboembolism: The most serious adverse reaction related to EVISTA was VTE (deep venous thrombosis, pulmonary embolism, and retinal vein thrombosis). During an average of study-drug exposure of 2.6 years, VTE occurred in about 1 out of 100 patients treated with EVISTA.